Presentation of investment projects of JSC BZMP 2019

Presentation of investment projects of JSC “BZMP” 2019 1

Open Joint Stock Company “Borisovskiy Zavod Medicinskikh Preparatov” (JSC “BZMP”) THE LARGEST PHARMACEUTICAL ENTERPRISE IN THE REPUBLIC OF BELARUS invites investors to create a joint venture of Drug Establishment. The main purpose of the investment project is to develop the production of popular medicines for supply both to the Republic of Belarus and to the countries of Eurasian Economic Union and abroad. 2

3

Joint venture establishment for the production of biological products Drug name Application area Immunoglobulins Rabies immunoglobulin, solution for Immunization against injection. rabies. Human immunoglobulin, solution for Prevention of hepatitis A, injection. measles, pertussis, etc. Coagulation factors IX, II, VII, and X, powder for injection. Coagulation factor IX concentrate, powder for injection. Coagulation factor VIII, powder for injection. 4 Treatment and prophylaxis of bleeding of various etiologies. Amount of investments – 30 mln $

Joint venture establishment for the production of biological products Drug name Application area Interleukins Interleukin-2, solution for injections. Treatment of septicemic conditions and several kinds of oncology diseases. Vaccines Inactivated poliomyelitis suspension for injections. vaccine, Anti-poliomyelitis vaccination. Hepatitis A vaccine, suspension for Anti-hepatitis A vaccination. injections for adult and pediatric use. Measles rubeola and parotitis vaccine, Anti-measles rubeola lyophilized powder. parotitis vaccination. other products (in total 15 items). 5 and Amount of investments – 30 mln $

Joint enterprise establishment for drug production with JSC “Borisovskiy Zavod Medicinskikh Preparatov” Drug name Application area Rentgenocontrast iodine containing preparations. Iohexol, solution for injection. Iopromid, solution for injection. Ioversol, solution for intravenous and intra-arterial injection. Iodixanol, intravascular injection solution. X-ray image contrast intensifying. Magnetic resonance contrast preparations. Gadobutrol, solution for intravenous injection. Gadodiamide, solution for intravenous injection. Gadoversetamide, solution for intravenous injection. and etc. (in total 10 items) 6 MRI contrast intensifying. Amount of investments – 25 mln $

FOR INVESTMENT PROJECTS REALIZATION ON JOINT VENTURES CREATION the Belarusian side: • provides a site for the construction of a joint venture; • provides development of design and estimate documentation support ; • ensures advertising qualified personnel for construction and installation works; • provides the necessary infrastructure; • finances expenses in accordance with its share of participation; • carries out drugs development , their registration and further operating time on the created production capacities. 7

FOR INVESTMENT PROJECTS REALIZATION ON JOINT VENTURES CREATION THE INVESTOR: • finances expenses in accordance with its share of participation; • introduces a new line of drugs and provides their production technology; • participates in design and estimate documentation development for construction, supervises the conduct of construction and installation works and financing; • offers its drug sales markets; • manages a joint venture. 8

WE INVITE YOU TO MUTUALLY BENEFICIAL CO-OPERATION! JSC “BZMP” 64 Chapaeva str. , Borisov Minsk region, 222518 The Republic of Belarus, Tel: (+375 177) 73 22 61 Fax: (+375 177) 73 24 25 E-mail: borimed@borimed. com www. borimed. com 9